Dosage and administration
Apply directly to the affected areas as directed by your veterinarian.
Apply directly to the affected areas as directed by your veterinarian.
• Store at room temperature 15˚ - 30˚C (58˚ - 86˚F). • Store in a cool, dry place.
Chlorhexidine Gluconate........2% (w/w)....................Antiseptic
Pramoxine HCL.....................1% (w/w).........Topical Anesthetic
Citronella Oil....................... 1% (w/w)............Insect Repellent
Hydrocortisone .................0.5% (w/w).........Anti-Inflammatory
EquiShield® IBH Salve is formulated to address insect bite hypersensitivity (IBH) allergic dermatitis. EquiShield® IBH is formulated to be a topical anesthetic with antiseptic and anti-inflammatory properties and a natural insect repellant. For use on horses.
Apply directly to the affected areas as directed by your veterinarian.
For external use only.
Keep out of reach of children.
Avoid contact with eyes or mucous membranes.
Consult your veterinarian before use.
• Store at room temperature 15˚ - 30˚C (58˚ - 86˚F).
• Store in a cool, dry place.
Made in U.S.A.
KINETIC™
P.O. Box 12388, Lexington, KY 40583
877.786.9882 • Fax: 859.258.9177
EquiShield® IBH SALVE
Insect Bite Hypersensitivity
FOR VETERINARY USE ONLY • KEEP OUT OF THE REACH OF CHILDREN
Net Contents: 4 oz (113 g)
| Class | Version | Type | Effective |
|---|---|---|---|
| CHLORHEXIDINE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| HYDROCORTISONE Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20180813 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51031-017-01 | EquiShield IBH Salve | 453 g in 1 CONTAINER | SALVE | 453 | 4 | |
| 51031-017-04 | EquiShield IBH Salve | 113 g in 1 CONTAINER | SALVE | 113 | 4 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CHLORHEXIDINE GLUCONATE | ACTIVE INGREDIENT | MOR84MUD8E | 1 | |
| CITRONELLA OIL | ACTIVE INGREDIENT | QYO8Q067D0 | 1 | |
| HYDROCORTISONE | ACTIVE INGREDIENT | WI4X0X7BPJ | 1 | |
| PRAMOXINE HYDROCHLORIDE | ACTIVE INGREDIENT | 88AYB867L5 | 1 | |
| CHLORHEXIDINE | ACTIVE MOIETY | R4KO0DY52L | 1 | |
| CITRONELLA OIL | ACTIVE MOIETY | QYO8Q067D0 | 1 | |
| HYDROCORTISONE | ACTIVE MOIETY | WI4X0X7BPJ | 1 | |
| PRAMOXINE | ACTIVE MOIETY | 068X84E056 | 1 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 51031-017 | 51031-017-04, 51031-017-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CHLORHEXIDINE GLUCONATE | MOR84MUD8E | ACTIB |
| PRAMOXINE HYDROCHLORIDE | 88AYB867L5 | ACTIB |
| CITRONELLA OIL | QYO8Q067D0 | ACTIB |
| HYDROCORTISONE | WI4X0X7BPJ | ACTIB |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Adverse event summaries are temporarily unavailable. Other product information remains available.